Cannabis, vulnerability, and the onset of schizophrenia: An epidemiological perspective

Australian and New Zealand Journal of Psychiatry

Volumn 34, Issue 3, 2000, Pages 468-475

  Hambrecht, Martin ^a   Häfner, Heinz ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Cannabis; Onset; Schizophrenia; Vulnerability

Indexed keywords

CANNABIS;

ADULT; ANAMNESIS; ARTICLE; CANNABIS ADDICTION; COPING BEHAVIOR; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GERMANY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; ONSET AGE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SELF MEDICATION; SEX DIFFERENCE;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGE OF ONSET; CATCHMENT AREA (HEALTH); CHILD; COMORBIDITY; FEMALE; GERMANY; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 0343183238     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2000.00736.x     Document Type: Article

References (37)

1. Rosenthal RN. Is schizophrenia addiction prone? Current Opinion in Psychiatry 1998: 11:45-48.
2. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent onset schizophrenic disorders. Archives of General Psychiatry 1994; 51:273-279.
3. Addington J, Addington D. Effect of substance misuse in early psychosis. British Journal of Psychiatry 1998; 172 (Suppl. 33): 134-136.
4. Baigent M, Holme G, Hafner RJ. Self reports of the interaction between substance abuse and schizophrenia. Australian and New Zealand Journal of Psychiatry 1995; 29:69-74.
5. Schneier FR, Siris SG. A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. Journal of Nervous and Mental Disease 1987; 175:641-652.
6. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry 1991; 148:224-230.
7. Arndt S, Tyrrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychological Medicine 1992; 22:379-388.
8. Warner R, Taylor D, Wright J et al. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. American Journal of Orthopsychiatry 1994; 63:30-39.
9. Soyka M, Albus M, Kathmann N et al. Prevalence of alcohol and drug abuse in schizophrenic inpatients. European Archives of Psychiatry and Clinical Neuroscience 1993; 242:362-372.
10. Mueser KT, Yarnold PR, Levinson DF et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophrenia Bulletin 1990; 16:31-56.
11. Mueser KT, Yarnold PR, Bellack AS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatrica Scandinavica 1992; 85:48-55.
12. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologie Catchment Area (FCA) Study. Journal of the American Medical Association 1990; 264:2511-2518.
13. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. Archives of General Psychiatry 1996; 53:1022-1031.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn. Washington: American Psychiatric Association, 1994.
15. Goldfinger SM, Schutt RK, Seidman LJ, Turner WM, Penk WE, Tolomiczenko GS. Self-report and observer measures of substance abuse among homeless mentally ill persons in the cross-section and over time. Journal of Nervous and Mental Disease 1996; 184:667-672.
16. Schwartz LS, Lyons JS, Stulp F, Hassan T, Jacobi N, Taylor J. Assessment of alcoholism among dually diagnosed psychiatric inpatients. Journal of Substance Abuse and Treatment 1993; 10:255-261.
17. Allebeck P, Adamsson C, Engstrom A, Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatrica Scandinavica 1993; 88:21-24.
18. Silver H, Abboud E. Drug abuse in schizophrenia: comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission. Schizophrenia Research 1994; 13:57-63.
19. Thornicroft G. Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry 1990; 157:25-33.
20. McGuire PK, Jones P, Harvey I, Williams M, McGuffin P, Murray RM. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophrenia Research 1995: 15:277-281.
21. Test MA, Wallisch LS, Allness DJ, Ripp K. Substance abuse in young adults with schizophrenic disorders. Schizophrenia Bulletin 1989; 15:465-476.
22. Noordsy DL, Drake RE, Teague GB et al. Subjective experiences related to alcohol use among schizophrenics. Journal of Nervous and Mental Disease 1991; 179:410-414.
23. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biological Psychiatry 1996; 40:1155-1163.
24. Docherty JP, van Kammen DP, Siris SG, Marder SR. Stages of onset of schizophrenic psychosis. American Journal of Psychiatry 1978; 135:420-426.
25. Häfner H, Riecher-Rössler A, Maurer K, Fätkenheuer B, Löffler W. First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences. European Archives of Psychiatry and Clinical Neuroscience 1992; 242:109-118.
26. Häfner H, Maurer K, Löffler W, Riecher-Rössler A. The influence of age and sex on the onset and early course of schizophrenia. British Journal of Psychiatry 1993; 162:80-86.
27. Häfner H, Riecher-Rössler A, Hambrecht M et al. IRAOS: an instrument for the retrospective assessment of the onset of schizophrenia. Schizophrenia Research 1992; 6:209-223.
28. Wing JK, Cooper JE, Sartorius N. Measurement and classification of psychiatric symptoms. Cambridge: Cambridge University Press, 1974.
29. Andreasen NC. Negative symptoms in schizophrenia. Archives of General Psychiatry 1982; 39:784-788.
30. World Health Organization. Psychiatric disability assessment schedule (WHO/DAS). Geneva: WHO. 1988.
31. Hambrecht M, Häfner H, Löffler W. Beginning schizophrenia observed by significant others. Social Psychiatry and Psychiatric Epidemiology 1994; 29:53-60.
32. Zubin J, Spring B. Vulnerability: a new view of schizophrenia. Journal of Abnormal Psychology 1977; 86:103-126.
33. Nuechterlein K. Vulnerability models for schizophrenia: state of the art. In: Häfner H, Janzarik W, eds. Search for the causes of schizophrenia. Berlin: Springer, 1987:297-316.
34. Castle DJ, Ames FR. Cannabis and the brain. Australian and New Zealand Journal of Psychiatry 1996: 30:179-183.
35. Lundquist T. Cognitive dysfunctions in chronic cannabis users. Stockholm: Almquist and Wiksell International. 1995.
36. Gardner EL, Lowinson JH. Marijuana's interaction with brain reward systems: update 1991. Pharmacology and Biochemistry of Behavior 1991; 40:571-580.
37. Bundesminister für Gesundheit. Daten des Gesundheitswesens Ausgabe 1991. Schriftenreihe des Bundesministeriums für Gesundheit. Bd. 3. Baden-Baden. Germany: Nomos, 1991.